Category Archives: Inducement to Infringe

The Cleveland Clinic Foundation et al. v. True Health Diagnostics LLC

Docket No. 2016-1766 LOURIE, REYNA, WALLACH June 16, 2017 Brief Summary: Patent directed at detecting myeloperoxidase release as a sign of cardiovascular disease ineligible under § 101. DC decision of no contributory or induced infringement affirmed since CCF fell “short … Continue reading

Posted in Contributory Infringement, Inducement to Infringe, Infringement, Patentability, Uncategorized | Leave a comment

Rivera et al. v. International Trade Commission and Solofill, LLC (Intervenor)

Docket No. 2016-1841 REYNA, LINN, CHEN May 23, 2017 Brief Summary: ITC decision of no § 337 violation because the asserted claims to a beverage brewer are invalid for lack of written description affirmed. Summary: Rivera appealed ITC holding that … Continue reading

Posted in Contributory Infringement, Importation, Inducement to Infringe, Infringement, International Trade Commission, Written description | Leave a comment

Braintree Laboratories, Inc. v. Breckenridge Pharmaceutical, Inc.

Docket No. 2016-1731 NEWMAN, MOORE, WALLACH May 5, 2017 Non-precedential Brief Summary: DC claim construction (e.g., previous Novel decision “foreclosed the [DC’s] construction of ‘from about 100 ml to about 500 ml’”) and infringement decisions reversed (e.g., claimed effects of … Continue reading

Posted in Claim Construction, Generics / ANDA, Inducement to Infringe, Infringement | Leave a comment

Tinnus Enterprises, LLC et al. v. Telebrands Corp. et al.

Docket No. 2016-1410 MOORE, WALLACH, STOLL January 24, 2017 Brief Summary: DC grant of PI and no invalidity for indefiniteness or obviousness affirmed. Summary: Telebrands appealed DC entry of preliminary injunction (PI) barring it from selling its “Balloon Bonanza, or … Continue reading

Posted in Analgous Art, Indefiniteness, Inducement to Infringe, Infringement, Obviousness | Leave a comment

Eli Lilly and Company v. Teva Parenteral Medicines, Inc. et al.

Docket No. 2015-2067 REYNA, HUGHES, STOLL January 12, 2017 Brief Summary: DC decision finding of direct infringement by physicians and induced infringement (§ 271(b)) by Teva as well as no obviousness affirmed. Summary: Teva et al. (“Teva”) appealed DC finding … Continue reading

Posted in Claim Differentiation, Indefiniteness, Inducement to Infringe, Infringement, Obviousness | Leave a comment

Medgraph, Inc. v. Medtronic, Inc.

Docket No. 2015-2019 LOURIE, PLAGER, TARANTO December 13, 2016 Brief Summary: DC dismissal of infringement claims against Medtronic affirmed because Medgraph did not prove “that some entity or group of entities performed all of the claimed steps” (Akamai V) and … Continue reading

Posted in Claim Construction, Contributory Infringement, Inducement to Infringe, Infringement | Leave a comment

Power Integrations, Inc. v. Fairchild Semiconductor Int., Inc. et al.

Docket No. 2015-1329, -1388 PROST, SCHALL, CHEN December 12, 2016 Brief Summary: Opinion addresses several grounds of appeal and cross-appeal in a long-running dispute (see, e.g., Power Int., FC 2015 and 2013) relating to the power supply controller chip market … Continue reading

Posted in Anticipation (35 USC 102), Claim Vitiation, Doctrine of equivalents, Inducement to Infringe, Infringement, Obviousness | Leave a comment